Atypical leiomyomas of the uterus: A clinicopathologic study of 51 cases

American Journal of Surgical Pathology

Volumn 37, Issue 5, 2013, Pages 643-649

  Ly, Amy ^a   Mills, Anne M ^a   McKenney, Jesse K ^a   Balzer, Bonnie L ^a   Kempson, Richard L ^a   Hendrickson, Michael R ^a   Longacre, Teri A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atypical leiomyoma; bizarre leiomyoma; smooth muscle tumor of uncertain malignancy; smooth muscle tumors of uncertain malignant potential

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HYSTERECTOMY; LEIOMYOMA; MIDDLE AGED; MYOMECTOMY; PATHOLOGY; TREATMENT OUTCOME; TUMOR RECURRENCE; UTERUS CANCER;

ADULT; AGED; FEMALE; HUMANS; HYSTERECTOMY; LEIOMYOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME; UTERINE MYOMECTOMY; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 84876688768     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182893f36     Document Type: Article

References (28)

1. Hertig A, Gore H. Tumors of the Vulva Vagina and Uterus. Washington DC: Armed Forces Institute of Pathology; 1960.
2. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18:535-558.
3. Scully RE, Bonfiglio TS, Kurman RJ, et al. Histological Typing of Female Genital Tract Tumors. New York: Springer-Verlag; 1994.
4. Downes KA, Hart WR. Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long-term follow-up. Am J Surg Pathol. 1997;21:1261-1270.
5. Fukunaga M, Ushigome S. Uterine bizarre lipoleiomyoma. Pathol Int. 1998;48:562-565.
6. Longacre TA, Hendrickson MR, Kempson RL. Predicting clinical outcome for uterine smooth muscle neoplasms with a reasonable degree of certainty. Adv Anat Pathol. 1997;4:95-104.
7. Evans H, Chawla S, Simpson C, et al. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer. 1988;62:2239-2247.
8. Hart W, Billman JJ. A reassessment of uterine neoplasms originally diagnosed as leiomyosarcomas. Cancer. 1978;41:1902-1910.
9. Takeda A, Imoto S, Mori M, et al. Successful pregnancy outcome after laparoscopic-assisted excision of a bizarre leiomyoma: a case report. J Med Case Rep. 2011;5:344.
10. Deodhar KK, Goyal P, Rekhi B, et al. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation. Indian J Pathol Microbiol. 2011;54:706-711.
11. Mills AM, Ly A, Balzer BL, et al. Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohisto-chemical study of 68 cases with clinical follow-up. Am J Surg Pathol. 2013. (In press).
12. Sun X, Mittal K. MIB-1 (Ki-67), estrogen receptor, progesterone receptor, and p53 expression in atypical cells in uterine symplastic leiomyomas. Int J Gynecol Pathol. 2010;29:51-54.
13. O'Neill CJ, McBride HA, Connolly LE, et al. Uterine leiomyosar-comas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential. Histo-pathology. 2007;50:851-858.
14. Mayerhofer K, Obermair A, Windbichler G, et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol. 1999;74:196-201.
15. Zhai YL, Kobayashi Y, Mori A, et al. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol. 1999;18:20-28.
16. Ip PP, Cheung AN, Clement PB. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases. Am J Surg Pathol. 2009;33:992-1005.
17. Bodner-Adler B, Bodner K, Czerwenka K, et al. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis. Gynecol Oncol. 2005;96: 62-66.
18. Atkins KA, Arronte N, Darus CJ, et al. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am J Surg Pathol. 2008;32:98-102.
19. Unver NU, Acikalin MF, Oner U, et al. Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors. Arch Gynecol Obstet. 2011;284:483-490.
20. Leiser AL, Anderson SE, Nonaka D, et al. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecol Oncol. 2006;101:86-91.
21. Yoo EH, Lee PI, Huh CY, et al. Predictors of leiomyoma recurrence after laparoscopic myomectomy. J Minim Invasive Gynecol. 2007;14:690-697.
22. Jin C, Hu Y, Chen XC, et al. Laparoscopic versus open myomectomy- A meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2009;145:14-21.
23. Veras E, Zivanovic O, Jacks L, et al. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas. Am J Surg Pathol. 2011;35: 1626-1637.
24. Karpuz V, Joris F, Letovanec N, et al. Metastizing low-grade clear cell leiomyosarcoma of the uterus. Pathol Int. 1998;48: 82-85.
25. Larrain D, Rabischong B, Khoo CK, et al. "Iatrogenic" parasitic myomas: unusual late complication of laparoscopic morcellation procedures. J Minim Invasive Gynecol. 2010;17:719-724.
26. Nezhat C, Kho K. Iatrogenic myomas: new class of myomas? J Minim Invasive Gynecol. 2010;17:544-550.
27. Tiltman AJ. Leiomyomas of the uterine cervix: a study of frequency. Int J Gynecol Pathol. 1998;17:231-234.
28. Ito H, Sasaki N, Miyagawa K, et al. Bizarre leiomyoblastoma of the cervix uteri. Immunohistochemical and ultrastructural study. Acta Pathol Jpn. 1986;36:1737-1745.